References
- SinghAStewartJMPathophysiology of diabetic macular edemaInt Ophthalmol Clin2009492111
- YangCMSurgical treatment for severe diabetic macular edema with massive hard exudatesRetina200020212112510783943
- AvciRKaderliBIntravitreal triamcinolone injection for chronic diabetic macular oedema with severe hard exudatesGraefes Arch Clin Exp Ophthalmol20062441283516034605
- AvciRKaderliBAkalpFDIntravitreal triamcinolone injection for chronic diffuse diabetic macular oedemaClin Exp Ophthalmol2006341273216451255
- CiardellaAPKlancnikJSchiffWBarileGLangtonKChangSIntravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography studyBr J Ophthalmol20048891131113615317702
- KhairallahMZeghidiHLadjimiAPrimary intravitreal triamcinolone acetonide for diabetic massive macular hard exudatesRetina200525783583916205560
- TakagiHOtaniAKiryuJOguraYNew surgical approach for removing massive foveal hard exudates in diabetic macular edemaOphthalmology19991062249256 discussion 256–2479951473
- NguyenQDBrownDMMarcusDMRanibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDEOphthalmology2012119478980122330964
- PempBDeakGPragerSDiabetic Retinopathy Research Group ViennaDistribution of intraretinal exudates in diabetic macular edema during anti-vascular endothelial growth factor therapy observed by spectral domain optical coherence tomography and fundus photographyRetina201434122407241525062440
- DomalpallyAIpMSEhrlichJSEffects of intravitreal ranibizumab on retinal hard exudate in diabetic macular edema: findings from the RIDE and RISE phase III clinical trialsOphthalmology2015122477978625601535
- LarssonJKifleyAZhuMRapid reduction of hard exudates in eyes with diabetic retinopathy after intravitreal triamcinolone: data from a randomized, placebo-controlled, clinical trialActa Ophthalmol200987327528018785964
- SutterFKSimpsonJMGilliesMCIntravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trialOphthalmology2004111112044204915522370
- MehtaHFraser-BellSYeungAEfficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trialBr J Ophthalmol201510071000100426537156
- Diabetic Retinopathy Clinical Research NetworkWellsJAGlassmanARAflibercept, bevacizumab, or ranibizumab for diabetic macular edemaN Engl J Med2015372131193120325692915
- GilbertEHLowensteinSRKoziol-McLainJBartaDCSteinerJChart reviews in emergency medicine research: where are the methods?Ann Emerg Med19962733053088599488
- EmeryJMKelman phacoemulsification, patient selectionEmeryJMMoIntyreDJExtracapsular cataract surgerySt Louis, MOCV Mosby198395100
- GonzalezRCWoodsREDigital Image ProcessingUpper Saddle River, NJPrentice Hall2008
- ScaramuzziMQuerquesGSpinaCLLattanzioRBandelloFRepeated intravitreal dexamethasone implant (Ozurdex) for diabetic macular edemaRetina20153561216122225574787
- MalclesADotCVoirinNSafety of intravitreal dexamethasone implant (Ozurdex): the safodex study. Incidence and risk factors of ocular hypertensionRetina201637713521359
- KimYHYunCKimJTKimSWOhJHuhKThe correlation between retinal sensitivity assessed by microperimetry and contrast sensitivity in diabetic macular oedemaBr J Ophthalmol201498121618162424997183
- VujosevicSMidenaEPilottoERadinPPChiesaLCavarzeranFDiabetic macular edema: correlation between microperimetry and optical coherence tomography findingsInvest Ophthalmol Vis Sci20064773044305116799051
- MastropasquaRTotoLBorrelliEMorphology and function over a one-year follow up period after intravitreal dexamethasone implant (Ozurdex) in patients with diabetic macular edemaPLoS One20151012e014566326720268
- QuerquesGLattanzioRQuerquesLImpact of intravitreal dexamethasone implant (Ozurdex) on macular morphology and functionRetina201434233034123945638